熱門資訊> 正文
EyePoint Pharmaceuticals申请4亿美元混合证券货架
2024-08-09 04:57
- EyePoint Pharmaceuticals (NASDAQ:EYPT) filed a prospectus related to the offer and sale of $400M mixed securities shelf.
- This prospectus is not an offer to sell.
- Filing
More on EyePoint Pharmaceuticals
- Seeking Alpha’s Quant Rating on EyePoint Pharmaceuticals
- Historical earnings data for EyePoint Pharmaceuticals
- Financial information for EyePoint Pharmaceuticals
風險及免責提示:以上內容僅代表作者的個人立場和觀點,不代表華盛的任何立場,華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前,應結合自身情況,考慮投資產品的風險。必要時,請諮詢專業投資顧問的意見。華盛不提供任何投資建議,對此亦不做任何承諾和保證。